Cleared Traditional

K062468 - SPECTRUM M2 MONITOR

K062468 is the FDA 510(k) clearance for SPECTRUM M2 MONITOR by Spectrum Medical, Llp. It is a Class 2 Cardiovascular device (product code DRY) cleared through the Traditional 510(k) pathway after a 20-day FDA review.

K062468 · Spectrum Medical, Llp · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2006
Decision
20d
Days
Class 2
Risk

K062468 is an FDA 510(k) clearance for the SPECTRUM M2 MONITOR. Classified as Monitor, Blood-gas, On-line, Cardiopulmonary Bypass (product code DRY), Class II - Special Controls.

Submitted by Spectrum Medical, Llp (Cheltenham, GB). The FDA issued a Cleared decision on September 13, 2006 after a review of 20 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Spectrum Medical, Llp devices

Submission Details

510(k) Number K062468 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 24, 2006
Decision Date September 13, 2006
Days to Decision 20 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
105d faster than avg
Panel avg: 125d · This submission: 20d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code DRY Monitor, Blood-gas, On-line, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRY Monitor, Blood-gas, On-line, Cardiopulmonary Bypass

All 21
Devices cleared under the same product code (DRY) and FDA review panel - the closest regulatory comparables to K062468.
CDI BLOOD PARAMETER MONITORING SYSTEM 500
K133658 · Terumo Cardiovascular Systems Corp. · Jul 2014
CDI BLOOD PARAMETER MONITORING SYSTEM 500
K123039 · Terumo Cardiovascular Systems Corp. · Nov 2012
BLOOD MONITORING UNIT, MODEL BMU 40
K090147 · Maquet Cardiopulmonary, AG · Apr 2009
3M CDI BLOOD PARAMETER MONITORING SYSTEM 500
K972962 · 3M Company · Nov 1997
CDI 100 EXTRACORPOREAL HEMATOCRIT/OXYGEN SATURATIO
K931968 · 3M Health Care, Ltd. · Nov 1993
CDI(TM) 300, 400 & 100, MODIFICATION
K915255 · 3M Company · Jan 1992